BRÈVE publiée le 19/01/2026 à 11:50, il y a 5 mois 25 jours Viromed Medical AG Advances with Ex-Vivo Lung Study Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study Preclinical Research Acceleration Saarland University Collaboration
COMMUNIQUÉ DE PRESSE publié le 19/01/2026 à 11:45, il y a 5 mois 25 jours Viromed Medical AG: Ex-vivo lung study marks milestone for research and approval Viromed Medical AG's ex-vivo lung study with Saarland University and MHH is a significant milestone for research & approval, accelerating development processes Research Approval Viromed Medical AG Cold Plasma Technology Ex-vivo Lung Study
BRÈVE publiée le 15/01/2026 à 09:53, il y a 5 mois 29 jours Viromed Medical AG passe aux actions nominatives Actionnaires Bourse Viromed Medical AG Actions Nominatives Technologie Du Plasma Froid
BRÈVE publiée le 15/01/2026 à 09:53, il y a 5 mois 29 jours Viromed Medical AG Transitions to Registered Shares Shareholders Stock Exchange Viromed Medical AG Registered Shares Cold Plasma Technology
COMMUNIQUÉ DE PRESSE publié le 15/01/2026 à 09:48, il y a 5 mois 29 jours Viromed Medical AG switches to registered shares Viromed Medical AG converts share capital from bearer shares to registered shares to enhance transparency and direct shareholder communication. Stock trading to commence under new ISIN DE000A40VZN7 Stock Exchange Transparency Viromed Medical AG Registered Shares Bearer Shares
BRÈVE publiée le 07/01/2026 à 14:20, il y a 6 mois 6 jours Viromed AG partage une mise à jour stratégique sur ses avancées en matière de technologies médicales Partenariats Mondiaux Maladies Respiratoires Viromed Medical AG Dispositifs Médicaux Innovants Technologie Du Plasma Froid
BRÈVE publiée le 07/01/2026 à 14:20, il y a 6 mois 6 jours Viromed AG Shares Strategic Update on MedTech Advancements Respiratory Diseases Global Partnerships Innovative Medical Devices Viromed Medical AG Cold Plasma Technology
COMMUNIQUÉ DE PRESSE publié le 07/01/2026 à 14:15, il y a 6 mois 6 jours Viromed AG: Strategic Update on Operational Focus and Value Creation Viromed Medical AG provides strategic update on operational focus and value creation in the field of cold plasma technology and medical devices development Medical Devices Value Creation Viromed Medical AG Cold Plasma Technology Operational Focus
BRÈVE publiée le 28/11/2025 à 17:33, il y a 7 mois 15 jours Viromed Medical AG and HELLMUT RUCK GmbH Enter Exclusive Distribution Agreement Distribution Agreement Medical Technologies Viromed Medical AG HELLMUT RUCK GmbH Plasma Devices
BRÈVE publiée le 28/11/2025 à 17:33, il y a 7 mois 15 jours Viromed Medical AG et HELLMUT RUCK GmbH concluent un accord de distribution exclusive Accord De Distribution Viromed Medical AG Technologies Médicales HELLMUT RUCK GmbH Dispositifs Plasma
Publié le 13/07/2026 à 18:00, il y a 5 heures 47 minutes CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Publié le 13/07/2026 à 18:00, il y a 5 heures 47 minutes PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Publié le 13/07/2026 à 18:00, il y a 5 heures 47 minutes THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Publié le 13/07/2026 à 21:35, il y a 2 heures 12 minutes ATHA Energy Announces Corporate Activities Update
Publié le 13/07/2026 à 20:00, il y a 3 heures 47 minutes IBC Announces Share-Based Compensation to Directors
Publié le 13/07/2026 à 19:30, il y a 4 heures 17 minutes NioCorp to Appear on CNBC's "Squawk Box Asia" Program Today at 8:30 p.m. ET
Publié le 13/07/2026 à 15:27, il y a 8 heures 20 minutes As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo
Publié le 13/07/2026 à 22:30, il y a 1 heure 16 minutes Half-year 2026 Results Media and Investor Conference Call and Webcast
Publié le 13/07/2026 à 21:20, il y a 2 heures 26 minutes Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Publié le 13/07/2026 à 21:17, il y a 2 heures 29 minutes EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Publié le 13/07/2026 à 20:48, il y a 2 heures 58 minutes EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Publié le 13/07/2026 à 20:23, il y a 3 heures 24 minutes EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations
